Deprescribing Cardiovascular Meds in Fra
Deprescribing Cardiovascular Medications in Frail Patients:
Deprescribing is the process of systematically discontinuing or reducing medications that may no longer benefit, or could potentially harm, a patient. In frail individuals, particularly older adults with cardiovascular diseases, polypharmacy (the use of multiple medications) is common. Frailty increases vulnerability to side effects, drug interactions, and worsened health outcomes. Deprescribing cardiovascular medications in these patients requires careful consideration of the patient’s overall health, life expectancy, and treatment goals. The approach focuses on balancing the risks of medications with their benefits, aiming to improve quality of life while minimizing adverse effects.
Key Considerations:
Comprehensive Review: Evaluate the patient’s medication list, including cardiovascular drugs like antihypertensives, statins, and antiplatelets.
Patient-Centered Approach: Engage in shared decision-making, discussing the risks and benefits with the patient and their caregivers.
Gradual Reduction: Tapering off medications rather than abrupt discontinuation to avoid withdrawal effects or sudden health deterioration.
Monitoring: Continuous monitoring for potential withdrawal effects or symptom changes after deprescribing.
More info : cardiology.pencis.com
Contact : cardiology@pencis.com
#Deprescribing
#cardiovascularhealth
#FrailPatients
#Polypharmacy
#elderlycare
#medicationmanagement
#SharedDecisionMaking
#healthyaging
#Frailty
.jpeg)
.png)
No comments:
Post a Comment